Follow
Pingfu Fu
Title
Cited by
Cited by
Year
Adherence to surgical care improvement project measures and the association with postoperative infections
JJ Stulberg, CP Delaney, DV Neuhauser, DC Aron, P Fu, SM Koroukian
Jama 303 (24), 2479-2485, 2010
6042010
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo–expanded UCB cells: results of a phase 1 trial using the AastromReplicell System
J Jaroscak, K Goltry, A Smith, B Waters-Pick, PL Martin, TA Driscoll, ...
Blood 101 (12), 5061-5067, 2003
3982003
Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion
S Shukla, GT MacLennan, DJ Hartman, P Fu, MI Resnick, S Gupta
International journal of cancer 121 (7), 1424-1432, 2007
3752007
Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry
JD Cramer, P Fu, KC Harth, S Margevicius, SM Wilhelm
Surgery 148 (6), 1147-1153, 2010
3592010
Nuclear factor-κB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression
S Shukla, GT MacLennan, P Fu, J Patel, SR Marengo, S Gupta
Neoplasia 6 (4), 390-400, 2004
2852004
Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid
P Savvides, G Nagaiah, P Lavertu, P Fu, JJ Wright, R Chapman, ...
Thyroid 23 (5), 600-604, 2013
2422013
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome
CJ Mooney, G Nagaiah, P Fu, JK Wasman, MM Cooney, PS Savvides, ...
Thyroid 19 (3), 233-240, 2009
2292009
The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study
GT MacLennan, R Eisenberg, RL Fleshman, JM Taylor, P Fu, MI Resnick, ...
The Journal of urology 176 (3), 1012-1016, 2006
2262006
Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model
S Gupta, VM Adhami, M Subbarayan, GT MacLennan, JS Lewin, ...
Cancer research 64 (9), 3334-3343, 2004
2212004
Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non–small cell lung cancer
M Khorrami, P Prasanna, A Gupta, P Patil, PD Velu, R Thawani, ...
Cancer immunology research 8 (1), 108-119, 2020
2172020
Kangaroo Care modifies preterm infant heart rate variability in response to heel stick pain: pilot study
X Cong, SM Ludington-Hoe, G McCain, P Fu
Early human development 85 (9), 561-567, 2009
2172009
Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients
M Rahman, P Fu, AR Sehgal, MC Smith
American journal of kidney diseases 35 (2), 257-265, 2000
2172000
Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non–small cell lung cancer
G Corredor, X Wang, Y Zhou, C Lu, P Fu, K Syrigos, DL Rimm, M Yang, ...
Clinical cancer research 25 (5), 1526-1534, 2019
2122019
Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma
S Gupta, T Hussain, GT MacLennan, P Fu, J Patel, H Mukhtar
Journal of Clinical Oncology 21 (1), 106-112, 2003
1972003
Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study
M Pandey, P Kaur, S Shukla, A Abbas, P Fu, S Gupta
Molecular carcinogenesis 51 (12), 952-962, 2012
1962012
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
S Shukla, N Bhaskaran, MA Babcook, P Fu, GT MacLennan, S Gupta
Carcinogenesis 35 (2), 452-460, 2014
1872014
Expansion of LTC-ICs and Maintenance of p21 and BCL-2 Expression in Cord Blood CD34+/CD38 Early Progenitors Cultured over Human MSCs as a Feeder …
S Kadereit, LS Deeds, SE Haynesworth, ON Koc, MM Kozik, E Szekely, ...
Stem Cells 20 (6), 573-582, 2002
1742002
Impairment of regulatory T-cell function in autoimmune thyroid disease
AB Glick, A Wodzinski, P Fu, AD Levine, DN Wald
Thyroid 23 (7), 871-878, 2013
1702013
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial
ED Baron, CL Malbasa, D Santo‐Domingo, P Fu, JD Miller, ...
Lasers in surgery and medicine 42 (10), 888-895, 2010
1702010
Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins
N Aldrich, M Gerstenblith, P Fu, MS Tuttle, P Varma, E Gotow, KD Cooper, ...
JAMA dermatology 151 (11), 1213-1219, 2015
1692015
The system can't perform the operation now. Try again later.
Articles 1–20